Key result
Female patients exhibited an increased risk of death associated with digoxin therapy for heart failure, whereas male patients appeared to have no increased risk.
Why the study?
Does digoxin therapy have sex-based differences in mortality risk in patients with heart failure?
Population
Patients with heart failure (discussed in the context of a previous report)
Design
Editorial
Authors
Loading...
This editorial highlights potential sex-based differences in the safety of digoxin for heart failure, emphasizing the need for greater enrollment of women in clinical studies.
Does digoxin therapy have sex-based differences in mortality risk in patients with heart failure?
This editorial highlights potential sex-based differences in the safety of digoxin for heart failure, emphasizing the need for greater enrollment of women in clinical studies.
M. P. Blaustein (2003) conducted an editorial in Heart failure. Digoxin was evaluated on Death. Female patients exhibited an increased risk of death associated with digoxin therapy for heart failure, whereas male patients appeared to have no increased risk.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: